Showing results (91-100 of 177) with videos related to
Sort By:
Pageof 18
Urology|February 19, 2008
Trends in Gleason score: concordance between biopsy and prostatectomy over 15 yearsAyyathurai Rajinikanth, Murugesan Manoharan, Cynthia T Soloway, et al.Diseases of the Colon and Rectum|November 15, 2002
Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factorsNeil A Abrahams, Amy Halverson, Victor W Fazio, et al.American Journal of Clinical Pathology|September 25, 2003
Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6Neil A Abrahams, David G Bostwick, Adrian H Ormsby, et al.European Urology|March 27, 2012
Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocolsViacheslav Iremashvili, Lisét Pelaez, Murugesan Manoharan, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 16, 2011
Oncological and functional outcomes following open radical prostatectomy: how patients may achieve the "Trifecta"?Elie Antebi, Ahmed Eldefrawy, Devendar Katkoori, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate diseaseEdna Gordian, Kavitha Ramachandran, Isildinha M Reis, et al.The Journal of Biological Chemistry|June 27, 2002
Regulation of hyaluronidase activity by alternative mRNA splicingVinata B Lokeshwar, Grethchen L Schroeder, Robert I Carey, et al.Urology|April 19, 2006
Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservationAlan M Nieder, Michael A Simon, Sandy S Kim, et al.BJU International|September 14, 2007
Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experienceMark S Soloway, Cynthia T Soloway, Steve Williams, et al.Urology|October 31, 2012
Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomyViacheslav Iremashvili, Lisét Pelaez, Mercé Jordá, et al.Pageof 18